INmune Bio Inc. - Common stock (INMB) Social Stream



INmune Bio Inc. - Common stock (INMB): $8.60

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INMB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

INMUNE BIO INC (INMB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering INMB.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 2 $42 $32 $37 $8.6 330.23%
2022-01-24 2 $42 $20 $31 $8.6 260.47%
2022-03-07 2 $42 $14 $28 $8.6 225.58%
2022-05-11 2 $22 $14 $18 $8.6 109.3%
2022-05-24 1 $22 $14 $18 $8.6 109.3%
2022-12-16 2 $22 $7 $14.333 $8.6 66.66%

Price Target Last Issued May 24, 2022

The Trend in the Analyst Price Target


INMB's average price target has moved down $15.17 over the prior 19 months.

INMB reports an average of 169.2% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-24 3 22 14 18.000 5.48 228.47%
2022-05-24 2 22 14 18.000 5.48 228.47%
2022-05-24 1 22 7 14.333 5.48 161.55%
2022-05-24 2 22 7 14.333 5.48 161.55%
2022-12-16 2 22 7 14.333 7.47 91.87%

INMB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


INMB's average broker recommendation rating worsened by 1 over the prior 48 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INMB as an investment opportunity.

  • INMB has a higher number of analysts covering the stock than 34.69% of all US stocks.
  • INMUNE BIO INC's upside potential (average analyst target price relative to current price) is greater than 646.21% of all US stocks.
  • INMB has a lower variance in analysts' estimates than -462.19% of stocks in the small market cap category.
  • INMUNE BIO INC's average analyst price target is greater than 430.61% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INMUNE BIO INC are GMDA, IMTX, and GRTS.

Make investment decisions regarding INMB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6779 seconds.